Activation of the Plasma Clotting, Fibrinolytic, and Kinin-Kallikrein System in Preterm Infants with Severe Idiopathic Respiratory Distress Syndrome

Brus, F; Vanoeveren, W; Okken, A; Oetomo, Sb

doi:10.1203/00006450-199411000-00020

Cited by 38 publications

(23 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fibrin and its derivatives impair endothelial cell function, increase vascular permeability [23], promote chemotaxis [24], immobilize leukocytes within the fibrin network [25] and activate complement and kinin-kallikrein systems [26]. These effects support the hypothesis that fibrin deposition is an important determinant of lung injury.…”

Section: Discussionsupporting

confidence: 65%

Plasminogen Did Not Affect Lung Function in Surfactant-Treated Preterm Lambs

Bhat

Jobe²,

Wert³

et al. 2000

Neonatology

View full text Add to dashboard Cite

Preterm infants with respiratory distress syndrome develop fibrin-rich hyaline membranes within the alveoli and have depressed fibrinolytic activity, which is thought to be due to a relative deficiency of plasminogen. Local fibrin deposition inhibits surfactant function and amplifies inflammation. We hypothesized that plasminogen administration to surfactant-treated preterm lambs would prevent fibrin-rich hyaline membrane formation, resulting in the amelioration of lung pathology and improved lung function. We randomly treated preterm lambs (gestational age 127–129 days) with either 16 mg of lysine-plasminogen (n = 10) or saline (n = 10), and ventilated them for 5 h. There were no significant differences in physiologic measurements of lung function (ventilation efficiency index, oxygenation index, dynamic compliance, quasi-static pressure volume curve), measures of lung injury (alveolar wash protein content and ¹²⁵I-albumin recovery) or surfactant pool size. The degree and extent of bronchiolar erosion and hyaline membrane formation were similar in the two groups. Plasminogen administration did not improve lung function or prevent hyaline membrane formation in surfactant-treated lambs.

show abstract

Section: Discussionsupporting

confidence: 65%

Plasminogen Did Not Affect Lung Function in Surfactant-Treated Preterm Lambs

Bhat

Jobe²,

Wert³

et al. 2000

Neonatology

View full text Add to dashboard Cite

show abstract

“…Recently Brus et al reported that in RDS and chronic lung disease in preterm infants, systemic activation of inflammation could be found also (10,11).…”

mentioning

confidence: 99%

Early Activation of Inflammation and Clotting in the Preterm Lamb with Neonatal RDS: Comparison of Conventional Ventilation and High Frequency Oscillatory Ventilation

Jaarsma¹,

Braaksma²,

Geven³

et al. 2001

Pediatr Res

Self Cite

View full text Add to dashboard Cite

“…Indeed, the severity of RDS has been linked to the systemic concentration of thrombin-antithrombin III complex (3). In addition, preterm babies with RDS are more likely than their peers to have systemic activation of inflammation (4,5). We do not yet know if products of coagulation and inflammation co-occur in the blood of infants destined to develop bronchopulmonary dysplasia.…”

Section: Respiratory Distress Syndrome (Rds) In Preterm Newbornsmentioning

confidence: 99%

Coagulation, Inflammation, and the Risk of Neonatal White Matter Damage

Leviton

Dammann

2004

Pediatr Res

View full text Add to dashboard Cite

Indicators of coagulation activation are sometimes increased in the blood of newborns and adults who have a systemic inflammatory response. These coagulation factors have the ability to exacerbate inflammation, which in turn can promote coagulation. Therapies directed solely at coagulation factors and therapies directed solely at inflammation factors have not proved effective in reducing mortality in adults with a systemic inflammatory response syndrome and multiorgan dysfunction (SIRS/MOD). On the other hand, the only therapy that has reduced mortality in SIRS/MOD is activated protein C, which has both anti-coagulation and anti-inflammatory effects. This and other observations support the view that activated coagulation factors enhance inflammation. Since newborns at risk of cerebral white matter damage and cerebral palsy are more likely than their peers to have a systemic inflammatory response, which is sometimes accompanied by elevated blood levels of coagulation factors, we suggest that activated coagulation factors contribute to the occurrence of cerebral white matter damage by exacerbating inflammatory phenomena, rather than by occluding cerebral blood vessels. Preterm newborns with respiratory distress syndrome and term newborns who develop cerebral palsy tend to have elevated blood levels of coagulation factors. In this essay, we suggest that these coagulation factors, when activated, produce their effects not so much by promoting coagulation as by promoting inflammation, a view supported by studies of adults with a systemic inflammatory response syndrome with multiorgan dysfunction (SIRS/MOD). We also suggest that activated systemic coagulation factors in the preterm newborn contribute to cerebral white matter damage (WMD) and to its clinical sequelae, including cerebral palsy (CP). NEWBORNS Respiratory distress syndrome (RDS) in preterm newborns.Fibrin is a major part of hyaline membranes, which are viewed as locally produced clots in neonatal RDS (1, 2). Indeed, the severity of RDS has been linked to the systemic concentration of thrombin-antithrombin III complex (3). In addition, preterm babies with RDS are more likely than their peers to have systemic activation of inflammation (4, 5). We do not yet know if products of coagulation and inflammation co-occur in the blood of infants destined to develop bronchopulmonary dysplasia.In newborn immature sheep with RDS, inflammation and clotting are activated shortly after birth (6). "Because activation of clotting and platelet activation are found later than activation of inflammation," Jaarsma and colleagues recently wrote, "we consider activation of clotting is not causative in RDS, but is activated secondary to activation of inflammation" (6).We postulate that this scenario of inflammation promoting coagulation also applies to neonatal WMD. Moreover, we postulate that inflammation promotes coagulation, which in turn further promotes inflammation (Fig. 1).CP in term newborns. Support for the systemic activation of both inflammation and coagulation in newb...

show abstract

Activation of the Plasma Clotting, Fibrinolytic, and Kinin-Kallikrein System in Preterm Infants with Severe Idiopathic Respiratory Distress Syndrome

Cited by 38 publications

References 9 publications

Plasminogen Did Not Affect Lung Function in Surfactant-Treated Preterm Lambs

Plasminogen Did Not Affect Lung Function in Surfactant-Treated Preterm Lambs

Early Activation of Inflammation and Clotting in the Preterm Lamb with Neonatal RDS: Comparison of Conventional Ventilation and High Frequency Oscillatory Ventilation

Coagulation, Inflammation, and the Risk of Neonatal White Matter Damage

Contact Info

Product

Resources

About